AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04737356 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Description: Internet-based CBT intervention based on CBT theory as well as self-determination therapy for low self-esteem among adolescents.
Study NCT04761575 — intervention group
Intervention type: OTHER
Intervention: Validation of the FFQ65+ via eNutri app
Description: All participants will provide two eNutri FFQ datasets within a 14-day interval along with three 24-hour dietary recalls and dried blood spot samples.
Study NCT04861506 — intervention group
Intervention type: PROCEDURE
Intervention: endovascular treatment
Description: All the patients are treated by endovascular therapy, through contralateral femoral artery approach, ipsilateral antegrade femoral artery approach or brachial artery approach. If the lesion is difficult to pass in antegrade approach, retrograde puncture at the distal artery of the lesion can be performed. Surgeons can choose treatment methods such as pharmacomechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) for thrombus removal according to the characteristics of the lesions and hospital conditions.
Study NCT05544201 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-definition transcranial current stimulation
Description: High-definition transcranial current stimulation (HD-tCS) is delivered by a battery driven direct current stimulator (DC-Stimulator Plus, NeuroConn, Ilmenau, Germany) through a central anodal electrode surrounded by four return cathodal electrodes.
Study NCT05544201 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High-definition transcranial current stimulation
Description: High-definition transcranial current stimulation (HD-tCS) is delivered by a battery driven direct current stimulator (DC-Stimulator Plus, NeuroConn, Ilmenau, Germany) through a central anodal electrode surrounded by four return cathodal electrodes.
Study NCT05544201 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: High-definition transcranial current stimulation
Description: High-definition transcranial current stimulation (HD-tCS) is delivered by a battery driven direct current stimulator (DC-Stimulator Plus, NeuroConn, Ilmenau, Germany) through a central anodal electrode surrounded by four return cathodal electrodes.
Study NCT04884386 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: robot-assisted gait training
Description: RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.
Study NCT04884386 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: conventional locomotion therapy
Description: locomotion exercise, postural control training, balance training, electrotherapy
Study NCT04884386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: conventional locomotion therapy
Description: locomotion exercise, postural control training, balance training, electrotherapy
Study NCT05856929 — intervention group
Intervention type: OTHER
Intervention: no Intervention
Description: no intervention
Study NCT05699239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-172 10mg bid
Description: oral administration of TS-172 10 mg bid
Study NCT05699239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-172 30mg bid
Description: oral administration of TS-172 30 mg bid
Study NCT05699239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-172 60mg bid
Description: oral administration of TS-172 60 mg bid
Study NCT05699239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-172 20mg tid
Description: oral administration of TS-172 20 mg tid
Study NCT04984070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Contraceptives, Combined
Description: One of the three medications like ethinylestradiol (35 μg) and cyproterone acetate, drospirenone and ethinylestradiol tablets (I) and (Ⅱ) will be used as an antiandrogen.
Study NCT05699239 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral administration of placebo
Study NCT05256888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-restricted eating
Description: 12 weeks of time-restricted eating (10-hour window)
Study NCT05256888 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Healthy lifestyle education
Description: Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks
Study NCT05256888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle education
Description: Weekly tips on healthy lifestyle behaviors (e.g., diet, exercise, sleep) for 12 weeks
Study NCT06474000 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin induction group
Description: Participants in the oxytocin induction group filled out the Information Form at the time of application to the delivery room. Routine care was performed. ALPS-Neo was filled before, during and at 5 minutes after the drying of the newborn within 1-40 minutes after birth. ALPS-Neo was filled before, during and 5 minutes after the first injection. ALPS-Neo was filled before, during and 5 minutes after the blood glucose measurement procedure.
Study NCT06474000 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Participants in the control group filled in the Information Form when they applied to the birth centre. Routine care was performed. ALPS-Neo was filled before, during and at 5 minutes after the drying of the newborn within 1-40 minutes after birth. ALPS-Neo was filled before, during and 5 minutes after the first injection. ALPS-Neo was filled before, during and 5 minutes after the blood glucose measurement procedure.
Study NCT05754398 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: six independent and interconnected educational training sessions
Description: Each of the six components will be offered each month for six consecutive months. Each session will last approximately 30 to 40 minutes.~All the six sessions will be delivered through a face-to-face approach.
Study NCT06428669 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitro-Bid 2 % Topical Ointment
Description: Intervention group will get 30mg of Nitro-Bid topical ointment applied over the chest (15mg/ 1 packet on each side) one time intra-operatively
Study NCT05214456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: The method of performing the dry needling technique will be based on the method presented by Dommerholt and Fernandez-de-las-Penas. The length of the needle (Tony, china) for each patient will be selected based on the size of the patient: 1) Multifidus: the patient will be placed in a prone position with a pillow under their belly to accommodate lumbar lordosis. The needles will be inserted into the lumbar multifidus muscles, 1.5 to 2 cm lateral to the spinous process of all lumbar vertebrates, perpendicular to the lamina (after piercing the skin, needles are directed inferomedially). 2) Quadratus lumborum: The patient will be placed in the side lying position with the side to be treated facing up. After identifying the lateral border of the quadratus lumborum muscle, the needle will be aimed straight downward in the direction of the transverse process, followed by slight anterior, posterior, and caudal needling to explore the entire muscle.
Study NCT05214456 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mobilization
Description: To perform Maitland's mobilization for lumbar spine, the anterior-posterior mobilization technique will be used and it is performed by pushing the heel (pisiform grip) or thumbs (thumb grip) to the vertebrae and can immediately reduce pain and restore motor function. First, the complete physical orthopedic evaluation of manual therapies will be performed using the Maitland evaluation method. Then, based on the findings of the patient evaluation, the severity, rhythm, duration and the degree of the mobilization and the place of force (spine or lamina) will be determined. To apply mobilization, the person will sleep in a prone position and the physiotherapist will use the heel of the hand or the thumbs to apply force to the first to fifth vertebrae of the lumbar spine. In segments that do not have a problem based on evaluation, first grade of the anterior-posterior Maitland's mobilization will be applied to the spinous process of the segment.
Study NCT05081167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REL-1017
Description: REL-1017 tablet
Study NCT05081167 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet
Study NCT05989750 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonic scaler
Description: Ultrasonic scaling for subgingival cleaning every 6 months for 2 years according to the manufacturer's procedures.
Study NCT06277947 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: China Hyperthermic Intraperitoneal Chemotherapy(C-HIPEC)
Description: The C-HIPEC would be performed at bedside in the general ward within 24 hours after surgery. The HIPEC treatment instruments are BR-TRG-II system, which can control the temperature stably to 43℃±0.1℃.
Study NCT05895877 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Goofice®
Description: Once daily before breakfast.
Study NCT05895877 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Goofice® Placebo
Description: Once daily before breakfast.
Study NCT05989750 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air-Flow Prophylaxis Master
Description: AIR-FLOW PROPHYLAXIS MASTER with erythritol powder (AIR FLOW Powder Plus) will be used every month for 2 years for subgingival cleaning according to the manufacturer's procedures.
Study NCT04984070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Pill
Description: Metformin is used to lower insulin resistance or to modulate hyperinsulinism.
Study NCT05387031 — intervention group
Intervention type: DRUG
Intervention: Ustekinumab
Description: The initial intravenous (IV) infusion with ustekinumab at baseline was weight-adjusted (260 mg ≤55 kg, 390 mg between 55 and 85 kg, 520 mg ≥85 kg). According to the label, the first subcutaneous (SC) 90 mg induction dose was administered at week 8 followed by a maintenance dose of 90 mg SC every 8 or 12 weeks, at the discretion of the physician. This study evaluated the CD disease activity, obstructive symptoms, and radiographic or endoscopic remission in patients at different follow-up time points, and comprehensively evaluated the efficacy of ustekinumab in relieving stenotic CD and its related factors.
Study NCT05012488 — intervention group
Intervention type: OTHER
Intervention: Comparison of gait and foot pressure
Description: The spatio temporal gait parameters of the patients will be evaluated with Zebris (Zebris Medical Limited , Germany) FDM (Force Distribution Measurement ) treadmill system. The system has production of 3D motion analysis and force measurement technologies for biomechanics. When the treadmill is in static and dynamic condition, strong pressure distribution measurement will be taken.
Study NCT04984070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Description: Weight control including calorie restriction and moderate exercise will be recommended to obese PCOS patients
Study NCT06135922 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EBV-TCR-T cells
Description: The patients with EBV-HLH or EBV infection will receive infusions of EBV-TCR-T cells, with the escalated dose ranging from 1×10\^6/kg to 1×10\^8/kg EBV-TCR-T cells per dose.
Study NCT05099341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HDRS-17 depression scale
Description: Measuring the severity of depression
Study NCT05726955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training program
Description: an exercise training program applied with conservative treatment and a stretching platform (ETSP) 3 days a week for 6 weeks
Study NCT04812769 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eCARE-ID
Description: The intervention, eCARE-ID, consists of: 1) telehealth video clinical consultation services for nursing homes residents; 2) electronic consultation services for healthcare personnel; 3) telehealth video antibiotic stewardship services for healthcare personnel
Study NCT04812769 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care
Description: Standard of care will be delivered to the control home.
Study NCT05984511 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: I-125 Seeds Brachytherapy in PVTT
Description: Iodine125 seed implantation into the PVTT was conducted 3-7 days after TACE when the results of the liver function tests were comparable to those obtained before TACE. Pre-procedural planning was conducted using a three-dimensional conformal radiation therapy treatment planning system (TPS) to determine the number of Iodine125 seeds required, the target location for implantation, the best percutaneous puncture site and the access route. The targeted zone for implantation was the tumour thrombosis in the segmental portal vein, left/right portal vein. Implantation was guided by CT, and the Iodine125 seeds were implanted into the PVTT using 18 G needles and the implantation gun that housed the Iodine125 seeds in the cartridge chamber.
Study NCT05984511 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcatheter arterial chemoembolization
Description: TACE: cTACE (conventional TACE) or dTACE (drug-eluting beads TACE).
Study NCT05984511 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization
Description: TACE: cTACE (conventional TACE) or dTACE (drug-eluting beads TACE).
Study NCT05984511 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atezolizumab plus Bevacizumab
Description: Atezolizumab/bevacizumab (1,200 mg atezolizumab plus 15 mg/kg bevacizumab intravenously every 3 weeks) .
Study NCT05984511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Bevacizumab
Description: Atezolizumab/bevacizumab (1,200 mg atezolizumab plus 15 mg/kg bevacizumab intravenously every 3 weeks) .
Study NCT05099341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HDRS-17 depression scale
Description: Measuring the severity of depression
Study NCT05297383 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Omega-3 Polyunsaturated Fatty Acid.
Description: 4 grams n-3 PUFA (AlaskOmega®) per day (3000 mg EPA and 1000 mg DHA).
Study NCT05297383 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Safflower Oil
Description: 4 grams safflower oil (AlaskOmega®) per day.
Study NCT05297383 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: High-Intensity Interval Training
Description: A 4 x 4 high-intensity interval training (HIIT) exercise program 3 days/week for 6 weeks. This will include a 3 min warm up at 15% watt max followed by 4 intervals for 4 min at 65% watt max with 3 min active recovery at 15% watt max.
Study NCT05297383 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: High-Intensity Interval Training
Description: A 4 x 4 high-intensity interval training (HIIT) exercise program 3 days/week for 6 weeks. This will include a 3 min warm up at 15% watt max followed by 4 intervals for 4 min at 65% watt max with 3 min active recovery at 15% watt max.
Study NCT05297383 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Flexibility Training
Description: 30 min of stretching 3 days/week for 6 weeks
Study NCT05297383 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Flexibility Training
Description: 30 min of stretching 3 days/week for 6 weeks
Study NCT06451055 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-calorie diet
Description: LCD diet is designed to provide \~1300 kcal/day with a macronutrient composition of 55% carbohydrate, 13% fat, 25% protein, and 2% fiber.
Study NCT06451055 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Routine dietary and physical activity habits
Description: Participants will be asked to maintain their habitual dietary and physical activity habits.
Study NCT05591430 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ganglion Impar Neurolysis
Description: block of Ganglion Impar by neurolytic drug
Study NCT05591430 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral S2, S3 and S4 Pulsed radiofrequency
Description: Bilateral S2, S3 and S4 Pulsed radiofrequency
Study NCT05609162 — intervention group
Intervention type: PROCEDURE
Intervention: neurosurgical resection
Description: neurosurgical resection, stereotactic radiosurgery (SRS), whole brain radiotherapy(WBRT), EGFR target drugs, Immune checkpoint inhibitors，cisplatin, temozolomide
Study NCT04819334 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Composition of Sports Drink
Description: The composition of sport drinks will be manipulated to determine the effect of drink composition on the appearance of ingested water in body fluid.
Study NCT04819334 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Composition of Sports Drink
Description: The composition of sport drinks will be manipulated to determine the effect of drink composition on the appearance of ingested water in body fluid.
Study NCT05099341 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood sampling
Description: 3 tubes of 5 ml
Study NCT05099341 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sampling
Description: 3 tubes of 5 ml
Study NCT05329701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized treatment duration strategy
Description: As listed under arm description.
Study NCT00519402 — intervention group
Intervention type: OTHER
Intervention: tonsillar examination and questionnaire completion
Study NCT06534554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Navigation
Description: A lay patient navigator working will contact patients seen in the UAB ED via phone within \~72 hours following the ED visit. During this initial phone conversation, the navigators will: 1) conduct a baseline assessment to identify barriers to attending an outpatient visit for gout care and to adhering to gout treatment recommendations and 2) determine the level of support and assistance needed by the patient.
Study NCT05844111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]-BGB-11417
Description: A single oral dose of liquid formulation
Study NCT06326008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy
Description: Peripheral blood mononuclear cells for the production of CD19 CAR T cells and CD22 CAR T cells are collected from donors and haematopoietic stem cells are collected from donors.
Study NCT05246761 — intervention group
Intervention type: DEVICE
Intervention: Balloon catheter
Description: In the two groups, if their bishop score \<6, they will receive the cervical riening by the balloon catheter, and then the oxytocin if necessary.
Study NCT05537272 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil 5mg
Description: Administration of Tadalafil 5mg once daily seven days before and seven days after prostate biopsy
Study NCT05537272 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamsulosin Hydrochloride 400 Microgram Prolonged-Release Oral Capsule
Description: Administration of Tamsulosin 0.4mg once daily seven days before and seven days after prostate biopsy
Study NCT05537272 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of placebo ( Vitamin C \[ascorbic acid\] 500mg tablet) once daily seven days before and seven days after prostate biopsy
Study NCT04781725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INT230-6
Description: INT230-6 is a formulation of two well known chemotherapeutic agents, cisplatin (0.5mg/mL) and vinblastine sulfate (0.1mg/mL), combined with 2-hydroxybenzoylaminooctanoate (also known as SHAO-FA or SHAO as a sodium salt at 10mg/mL).
Study NCT04781725 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline injection
Description: Standard 0.9 % NaCl Normal Saline
Study NCT04781725 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline injection
Description: Standard 0.9 % NaCl Normal Saline
Study NCT06161324 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PFM exercises program through the Mobile app in cooperation with the superficial sensor
Description: The mobile app will offer a personalized progressive protocol to the user based on his needs, via 12 levels of games(from the easiest to the hardest).The cooperating PFM superficial sensor will indicate the activity of the PFMs during the contraction.Νο face-to-face meetings will be incurred between participants and therapist.~Participants will follow a program for 12 weeks(3 times weekly, 1-5 sessions daily, each session's duration approximately 20 minutes).Endurance training will involve slow velocity contraction and speed training will involve quick (i.e.1 sec duration) strong contractions.Knack maneuver training will contain a pre-contraction before the increment of the intra-abdominal pressure during coughing. The exercise positions will change every 2 weeks (supine, side, prone, quadruped support, sitting and standing position).